نتائج البحث - "• glycoprotein IIb/ IIIa inhibitors"

المساهمون: RS: Carim - H01 Clinical atrial fibrillation, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: CARIM - R2.01 - Clinical atrial fibrillation, Fabris, Enrico, Ottervanger, Jan Paul, Hermanides, Renicus S., ten Berg, Jurrien M., Sinagra, Gianfranco, Koopmans, Petra C., Giannitsis, Evangelo, Hamm, Christian, van ‘t Hof, Arnoud W. J.

المصدر: Catheterization and Cardiovascular interventions, 93(5), E293-E297. Wiley

مصطلحات موضوعية: Male, Radiology, Nuclear Medicine and Imaging, Emergency Medical Services, tirofiban, Time Factors, medicine.medical_treatment, glycoprotein IIb/IIIa inhibitors, 030204 cardiovascular system & hematology, INITIATION, 0302 clinical medicine, Risk Factors, Nuclear Medicine and Imaging, Natriuretic Peptide, Brain, Natriuretic peptide, REPERFUSION, ST-SEGMENT ELEVATION, Prospective Studies, 030212 general & internal medicine, Myocardial infarction, General Medicine, Tirofiban, Middle Aged, ADMISSION, PROGNOSTIC VALUE, INSIGHTS, Treatment Outcome, Female, Radiology, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, medicine.drug_class, glycoprotein IIb/IIIa inhibitor, Lower risk, Placebo, Risk Assessment, Drug Administration Schedule, STEMI, 03 medical and health sciences, Percutaneous Coronary Intervention, Double-Blind Method, Fibrinolytic Agents, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, cardiovascular diseases, Aged, IIIa inhibitors, business.industry, MORTALITY, ELEVATION MYOCARDIAL-INFARCTION, EXTENT, Percutaneous coronary intervention, medicine.disease, Peptide Fragments, NT-proBNP, Glycoprotein IIb/IIIa inhibitors, Conventional PCI, ST Elevation Myocardial Infarction, glycoprotein IIb, business, Biomarkers, Platelet Aggregation Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c69b22291a1334f49239a8c536c72eTest
https://cris.maastrichtuniversity.nl/en/publications/648a3baa-80c1-48b0-819c-171b3ee3b642Test

9

Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI

المؤلفون: Renicus S Hermanides, Arnoud W J van 't Hof, Dominick J. Angiolillo, Anne H. Tavenier, Enrico Fabris

المساهمون: Tavenier, A. H., Hermanides, R. S., Fabris, E., Angiolillo, D. J., van 't Hof, A. W. J., RS: Carim - H01 Clinical atrial fibrillation, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9)

المصدر: International Journal of Cardiology, 328, 40-45. Elsevier Ireland Ltd

مصطلحات موضوعية: PRIMARY PCI, medicine.medical_treatment, PREHOSPITAL TICAGRELOR, Hemodynamics, 030204 cardiovascular system & hematology, Intestinal absorption, 0302 clinical medicine, P2Y12, ANTIPLATELET ACTION, inhibitors, Medicine, 030212 general & internal medicine, Myocardial infarction, Antiplatelet therapy, Glycoprotein IIb/IIIa inhibitors, P2Y, 12, STEMI, Blood Platelets, Humans, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists, Treatment Outcome, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, ST-SEGMENT-ELEVATION, inhibitor, surgical procedures, operative, Cardiology, Cardiology and Cardiovascular Medicine, GLYCOPROTEIN IIB/IIIA INHIBITORS, medicine.drug, Human, medicine.medical_specialty, Bridging (networking), PERCUTANEOUS CORONARY INTERVENTION, Glycoprotein IIb/IIIa inhibitor, 03 medical and health sciences, Internal medicine, Glycoprotein IIb, cardiovascular diseases, MYOCARDIAL-INFARCTION PATIENTS, IIIa inhibitors, LONG-TERM MORTALITY, business.industry, Platelet Aggregation Inhibitor, HIGH-DOSE TIROFIBAN, Percutaneous coronary intervention, medicine.disease, Purinergic P2Y Receptor Antagonist, Conventional PCI, Blood Platelet, business, TASK-FORCE

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194407af1f1a98f01a7a80a6a5b00728Test
https://hdl.handle.net/11368/3020745Test

10

Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention

المؤلفون: Dominick J. Angiolillo, Piera Capranzano

مصطلحات موضوعية: medicine.medical_specialty, Acute coronary syndrome, medicine.medical_treatment, Gastric motility, 030204 cardiovascular system & hematology, glycoprotein IIb/IIIa inhibitors, Gastroenterology, chewed, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, P2Y12, Cangrelor, Percutaneous Coronary Intervention, Internal medicine, Internal Medicine, medicine, Humans, 030212 general & internal medicine, Acute Coronary Syndrome, Clinical Trials as Topic, business.industry, Percutaneous coronary intervention, Disease Management, Thrombosis, General Medicine, Oral P2Y12 inhibitors, pretreatment, medicine.disease, chemistry, Glycoprotein IIb/IIIa inhibitors, Conventional PCI, Practice Guidelines as Topic, Purinergic P2Y Receptor Antagonists, Onset of action, crushed, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors, medicine.drug, cangrelor

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa7150237d8cca6056e6b4c47213ba8Test
https://hdl.handle.net/20.500.11769/541699Test

تنقيح النتائج